This past week, the venture capital landscape was dominated by an extraordinary influx of capital, signaling robust investor confidence in transformative technologies, particularly within artificial intelligence, robotics, and sustainable energy. The sheer scale of the funding rounds announced between February 7th and 13th underscores a period of aggressive investment, with several companies securing nine-figure sums and one reaching an unprecedented multi-billion dollar valuation. For those diligently tracking the most significant startup funding deals for U.S.-based companies, especially those exceeding $100 million, the Crunchbase Megadeals Board remains the essential resource, offering a curated and up-to-the-minute list for 2025 and beyond. Following last week’s impressive roundup, which highlighted major investments in AI and autonomous vehicles, this week’s announcements have set new benchmarks, with generative AI giant Anthropic leading the charge and profoundly shaping the narrative of venture finance in the mid-2020s.

Indeed, this week was characterized by funding deals boasting an impressive array of zeroes. At the apex of this financial crescendo was Anthropic, the generative AI powerhouse that secured a staggering $30 billion in its Series G funding round. This monumental investment not only propelled the San Francisco-based company to a colossal $380 billion post-money valuation but also marked the single largest venture funding deal of 2026 so far, and the second-largest venture funding round ever recorded by Crunchbase data. The sheer magnitude of this raise reflects the intense competition and immense potential perceived in the generative AI sector, where Anthropic, with its focus on developing reliable and steerable AI models like Claude, stands as a formidable player. The round was co-led by an impressive syndicate of global investors, including GIC and Coatue, alongside significant contributions from D.E. Shaw & Co. Ventures, Dragoneer Investment Group, Founders Fund, Iconiq Capital, and MGX. This collective endorsement from such a diverse group of high-profile investors underscores Anthropic’s strategic importance and its anticipated role in shaping the future of artificial intelligence, particularly in enterprise applications and ethical AI development. The capital injection is expected to fuel further research and development, accelerate product deployment, and expand Anthropic’s market reach in a rapidly evolving and highly competitive AI ecosystem.

Following Anthropic’s record-breaking achievement, other companies also commanded substantial investments, highlighting diverse areas of innovation attracting significant capital.

2. Apptronik, $520M, Humanoid Robots: Austin, Texas-based Apptronik, a trailblazer in AI-powered robotics, successfully secured an additional $520 million in new financing. This substantial investment serves as an extension to its already impressive $415 million Series A raise from February 2025, bringing the total for this round to over $935 million. The cumulative funding underscores the growing conviction in the potential of humanoid robots to revolutionize various industries, from manufacturing and logistics to healthcare and service sectors. Apptronik’s focus on developing versatile and intelligent robotic systems capable of operating in human environments positions it at the forefront of a burgeoning market. This capital infusion will likely accelerate the development and commercialization of their advanced robotic platforms, enhancing their capabilities in mobility, manipulation, and human-robot interaction. The significant backing from investors signals a belief that Apptronik is poised to lead the charge in making humanoid robots a practical reality, addressing labor shortages and enhancing operational efficiencies across numerous industries.

3. Inertia Enterprises, $450M, Fusion Energy: In the realm of clean energy, Livermore, California-based Inertia Enterprises, a two-year-old startup dedicated to fusion power, made waves by announcing $450 million in Series A funding. This substantial investment highlights the venture community’s increasing appetite for ambitious, long-term solutions to global energy challenges. Fusion energy, often hailed as the holy grail of clean power, promises virtually limitless, carbon-free electricity by mimicking the process that powers the sun. While still facing significant scientific and engineering hurdles, the influx of capital into companies like Inertia Enterprises indicates a renewed optimism that commercially viable fusion power is within reach. Bessemer Venture Partners led this pivotal round, joined by notable backers such as Google Ventures and Threshold. This funding will be crucial for Inertia Enterprises to advance its research, develop innovative reactor designs, and overcome the immense technical complexities inherent in harnessing fusion reactions, moving closer to a sustainable energy future.

4. Axiom Space, $350M, Space Tech: Houston-based Axiom Space, a leading player in the burgeoning commercial space industry, successfully closed $350 million in new financing. This unicorn startup is at the vanguard of developing a successor to the venerable International Space Station (ISS) and is also critically involved in developing next-generation spacesuits for future lunar missions. As governments increasingly look to private industry to drive space exploration and utilization, companies like Axiom Space are becoming indispensable. The investment, led by Type One Ventures and the Qatar Investment Authority, reflects a strong belief in the commercial viability of space infrastructure and services. Axiom’s plans include building the world’s first commercial space station, offering a platform for research, manufacturing, and even space tourism. This capital will accelerate the design, construction, and deployment of its modules, further solidifying its position as a key architect of humanity’s off-world future and expanding the reach of the new space economy.

5. Runway, $315M, AI: In the dynamic field of creative AI, Runway, an AI research and technology startup based in New York, secured $315 million in a Series E round. This financing, led by General Atlantic, significantly boosted the company’s valuation to $5.3 billion, a substantial increase from its $3.3 billion valuation just last April. Runway is a pioneer in generative AI for video, offering powerful tools that empower creators to produce high-quality video content with unprecedented speed and efficiency. Its platform leverages advanced machine learning models to enable features like text-to-video generation, style transfer, and intelligent editing, democratizing complex video production. The substantial investment underscores the explosive growth and transformative potential of AI in creative industries, signaling a future where AI tools will be integral to content creation across film, advertising, and digital media. This funding will enable Runway to further refine its models, expand its feature set, and solidify its leadership in the rapidly evolving landscape of AI-powered creative tools.

6. Talkiatry, $210M, Mental Health: Addressing the critical need for accessible mental healthcare, New York-based Talkiatry, a provider of in-network psychiatry services to health systems and employers, successfully raised $210 million in Series D funding. This round, led by Perceptive Advisors, brings the company’s total funding to date to more than $400 million. Talkiatry’s model focuses on integrating psychiatric care seamlessly into existing healthcare networks, thereby making mental health services more affordable and available to a broader population. By working directly with insurance providers, Talkiatry removes significant financial barriers that often prevent individuals from seeking necessary mental health support. This substantial investment reflects the urgent demand for scalable and integrated mental healthcare solutions, particularly in an era where awareness of mental well-being is at an all-time high. The capital will enable Talkiatry to expand its network of providers, enhance its technology platform, and reach more patients in need across the U.S.

7. Solace Health, $130M, Healthcare: Redwood City, California-based Solace Health, a digital platform dedicated to connecting patients with expert healthcare advocates, raised $130 million in Series C funding. This round, led by IVP, propelled the four-year-old company to a valuation exceeding $1 billion, granting it coveted unicorn status. In an increasingly complex healthcare system, navigating insurance claims, understanding medical bills, and coordinating care can be overwhelming for patients. Solace Health provides a crucial service by offering personalized advocacy, helping individuals make informed decisions and ensure they receive appropriate and affordable care. The significant investment highlights the growing recognition of the value of patient advocacy and the potential of digital platforms to simplify and humanize the healthcare experience. This funding will allow Solace Health to scale its platform, expand its network of advocates, and ultimately empower more patients to navigate their healthcare journeys with greater ease and confidence.

8. Garner Health, $118M, Healthcare: Another New York-based healthcare innovator, Garner Health, secured $118 million in Series D financing. Garner Health operates a digital platform designed to help patients find the highest-quality healthcare providers for their specific needs. By leveraging data analytics and advanced algorithms, Garner Health aims to cut through the noise and provide personalized recommendations for physicians and specialists who deliver superior outcomes. This round, led by Kleiner Perkins, underscores the ongoing drive to improve healthcare quality and efficiency through data-driven solutions. For both patients and employers, finding the right provider can lead to better health outcomes and significant cost savings. The investment will enable Garner Health to further enhance its predictive analytics capabilities, expand its provider network, and deepen its impact on how individuals access and experience healthcare.

9. (tied) Simile, $100M, AI Simulation: Palo Alto, California-based Simile, a nascent startup specializing in applying AI to create sophisticated simulated environments and simulation tools with AI agents, raised $100 million in Series A funding. This significant early-stage investment, led by Index Ventures, highlights the growing importance of simulation in the development and testing of complex AI systems. Simile’s technology could revolutionize fields ranging from autonomous vehicle development and robotics training to urban planning and scientific research. By creating realistic virtual worlds populated by intelligent AI agents, Simile allows for rapid prototyping, extensive testing, and the exploration of scenarios that would be costly or impossible to replicate in the real world. This capital infusion will be instrumental in building out Simile’s core technology, expanding its team of AI and simulation experts, and demonstrating the transformative potential of AI-powered simulation across diverse industries.

9. (tied) Loyal, $100M, Dog Longevity: In a unique and increasingly recognized niche, San Francisco-based Loyal, a startup dedicated to developing drugs to extend the healthy lifespans of senior dogs, raised $100 million in Series C funding. This investment, led by venture fund Age1, is designed to provide the necessary capital to transition the seven-year-old company from late-stage development to market readiness. As pets increasingly become integral family members, the demand for advanced veterinary care and solutions that improve their quality of life and longevity is surging. Loyal’s pioneering work in developing pharmaceuticals aimed at slowing the aging process in dogs represents a significant leap forward in veterinary medicine. This funding will be crucial for conducting final clinical trials, navigating regulatory approvals, and preparing for the commercial launch of its innovative treatments, ultimately aiming to give beloved canine companions more healthy years with their families.

The week of February 7-13, 2025, unequivocally demonstrated the venture capital market’s continued enthusiasm for high-impact innovation. From the monumental strides in generative AI and humanoid robotics to the crucial advancements in sustainable energy, space exploration, and digital healthcare, investors are clearly backing companies poised to redefine industries and solve some of the world’s most pressing challenges. Even specialized fields like AI simulation and pet longevity are attracting substantial capital, reflecting a broad-based confidence in technological progress. The prevalence of megadeals this week, especially Anthropic’s record-breaking round, underscores a market dynamic where leading innovators are commanding vast resources to accelerate their growth and secure their competitive advantage. This concentration of capital into a select group of high-potential ventures suggests a strategic focus on scale and impact, even as the broader economic landscape continues to evolve. The data, meticulously tracked within the Crunchbase database for U.S.-based companies, provides a clear snapshot of this vibrant and aggressive investment environment.

Stay up to date with recent funding rounds, acquisitions, and more with the Crunchbase Daily.

Illustration: Dom Guzman